Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Colombo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Open Forum Infectious Diseases|July 25, 2022
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Nusrat J Epsi, David A Lindholm, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Open Forum Infectious Diseases|July 25, 2022
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Nusrat J Epsi, David A Lindholm, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Open Forum Infectious Diseases|December 15, 2021
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon D Pollett, Charlotte A Lanteri, et al.
The Journal of Infectious Diseases|October 21, 2021
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Eric D Laing, Jarina Pena DaMata, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Open Forum Infectious Diseases|December 22, 2023
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, Ann I Scher, Jennifer Rusiecki, et al.
The Journal of Infectious Diseases|June 25, 2024
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelaeNusrat J Epsi, Josh G Chenoweth, Paul W Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Pageof 5